Skip to main content

Abstract

Objective:

The authors explored whether neighborhood context is associated with psychotropic polypharmacy and psychotherapy among a cohort of children with high needs for psychiatric and general medical care.

Methods:

Electronic health record data from a large health care system were used in a cross-sectional design to examine psychotropic polypharmacy and psychotherapy in 2015–2019 among children ages 2–17 years (N=4,017) with geocoded addresses. Inclusion criteria were a diagnosis of a mental health condition, an intellectual and developmental disability, or a complex medical condition and one or more clinical encounters annually over the study period. Polypharmacy was defined as two or more psychotropic drug class prescriptions concurrently for ≥60 days. Psychotherapy was defined as receipt of any psychotherapy or adaptive behavior treatment. Neighborhood context (health, environment, education, and wealth) was measured with the Child Opportunity Index. Multilevel generalized linear mixed models with random intercept for census tracts were used to assess the associations between individual and neighborhood characteristics and psychotropic polypharmacy and psychotherapy.

Results:

Moderate (vs. low) child opportunity was associated with higher odds of polypharmacy (adjusted OR [AOR]=1.79, 95% CI=1.19–2.67). High (vs. low) child opportunity was associated with higher odds of psychotherapy (AOR=2.15, 95% CI=1.43–3.21). Black (vs. White) race (AOR=0.51, 95% CI=0.37–0.71) and Hispanic ethnicity (AOR=0.44, 95% CI=0.26–0.73) were associated with lower odds of polypharmacy.

Conclusions:

Among high-need children, neighborhood Child Opportunity Index, race, and ethnicity were significantly associated with treatment outcomes in analyses adjusted for clinical factors. The findings underscore concerns about structural disparities and systemic racism and raise questions about access.

Get full access to this content

View all available purchase options and get full access to this content.

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services
Psychiatric Services
PubMed: 39257315

History

Received: 21 December 2023
Revision received: 9 May 2024
Revision received: 19 June 2024
Accepted: 3 July 2024
Published online: 11 September 2024

Keywords

  1. Child Opportunity Index
  2. Children with psychiatric conditions
  3. Complex medical conditions
  4. Intellectual and developmental disability
  5. Psychotropic polypharmacy

Authors

Details

Kathleen C. Thomas, Ph.D., M.P.H. [email protected]
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Izabela E. Annis, M.S.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Neal A. deJong, M.D., M.P.H.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Robert B. Christian, M.D.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Scott A. Davis, Ph.D.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Phillip M. Hughes, Ph.D., M.S.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Beth A. Prichard, B.A.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Jason R. Prichard, B.A.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Pamela S. Allen, R.N.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Joshua S. Gettinger, M.D.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
D'Jenne-Amal N. Morris, B.A.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).
Kerri B. Eaker
Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill (UNC) Eshelman School of Pharmacy, Chapel Hill (Thomas, Annis, Davis, Hughes); UNC Cecil G. Sheps Center for Health Services Research, Chapel Hill (Thomas, Hughes); Departments of Pediatrics (deJong, Christian) and Psychiatry (Christian), UNC School of Medicine, Chapel Hill; Parent Advisory Group, UNC Eshelman School of Pharmacy, Chapel Hill (B. A. Prichard, J. R. Prichard, Allen, Gettinger, Morris, Eaker).

Notes

Send correspondence to Dr. Thomas ([email protected]).
Parts of this work have been presented at the Workshop on Costs and Assessment in Psychiatry: Mental Health Services, Economics and Policy Research, Venice, Italy, March 25–27, 2022; the International Health Economics Association Congress, virtual, July 12–15, 2021; and the annual research meeting of AcademyHealth, virtual, June 14–17, 2021.

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

This work was supported by an award from the UNC Chapel Hill NIH-funded Clinical and Translational Science Award “NCTraCS” (UL1TR002489/SE2001) and a Division of Pharmaceutical Outcomes and Policy UNC Eshelman School of Pharmacy pilot award. Dr. Hughes was funded by an Eshelman Award from the UNC Eshelman School of Pharmacy and a National Research Service Award predoctoral/postdoctoral traineeship from the Agency for Healthcare Research and Quality sponsored by the UNC Cecil G. Sheps Center for Health Services Research (grant T32-HS000032).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share